Autism Fact Sheet | California's Stem Cell Agency
Stories of Hope: Autism | California's Stem Cell Agency
A major difference between the Sutter trial and those in China is that his will use the child’s own stem cells, rather than those from a donor. Chez hypothesizes that one way autologous stem cell infusion might work is by reducing inflammation within the body’s immune system. This would answer previous research that suggests that autism may be an autoimmune disease. “One of our exploratory goals will be to look at inflammatory markers in cells,” he says.
Stem Cell Therapy for Autism Shows Promise
Families with autistic children must navigate a condition where questions outnumber the answers, and therapies remain sparse and largely ineffective. A clinical being conducted by the in Sacramento, California to address this situation began recruiting participants today for a highly experimental stem cell therapy for autism. The institute plans to find 30 autistic children between ages 2 and 7 with cord blood banked at the privately-run , located about 100 miles west of the institute. Already one other clinical trial, with 37 total participants between ages 3 and 12 years old, has been completed in . The researchers affiliated with Beike Biotechnology in Shenzhen, the that sponsored the study, have not yet published any papers from that the trial, which used stem cells from donated cord blood. Mexican researchers are recruiting kids for yet another type of autism stem cell trial that will harvest cells from the participant’s fat tissue.